Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PTH 1-84 versus risedronate after sequential prior osteoporosis therapy
2005-000730-20Phase 3Completed
- Sponsor
- Nycomed
- Start
- Nov 2005
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in postmenopausal osteoporosis comparing PTH (1-84) in period III with Risedronate in period III (2 arms). Started Nov 2005; status: completed.
02
Drugs
parathyroid hormone 1-84risedronate
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on 2005-000730-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000730-20.